Compare AVNT & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNT | ITGR |
|---|---|---|
| Founded | 1927 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.7B |
| IPO Year | 1993 | 2000 |
| Metric | AVNT | ITGR |
|---|---|---|
| Price | $33.01 | $80.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $45.67 | ★ $95.00 |
| AVG Volume (30 Days) | ★ 786.2K | 603.0K |
| Earning Date | 02-12-2026 | 02-19-2026 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.23 | ★ 2.42 |
| Revenue | ★ $3,246,100,000.00 | $1,831,074,000.00 |
| Revenue This Year | $2.24 | $9.58 |
| Revenue Next Year | $2.35 | N/A |
| P/E Ratio | ★ $25.97 | $32.88 |
| Revenue Growth | 1.03 | ★ 9.54 |
| 52 Week Low | $27.48 | $62.00 |
| 52 Week High | $44.78 | $146.36 |
| Indicator | AVNT | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 67.27 | 65.82 |
| Support Level | $31.09 | $76.21 |
| Resistance Level | $31.82 | $79.48 |
| Average True Range (ATR) | 0.63 | 2.32 |
| MACD | 0.15 | 0.44 |
| Stochastic Oscillator | 95.51 | 90.14 |
Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.